Another green day and news? Things are looking up!
After reading the news, overall I'm quite excited! I think it lays out a really good long-term plan. I kind of figured they were working out some items to complete FDA approval. And I'm glad they're being transparent about it and are expecting to wrap that up soon. But the parts that get me really excited are:
1. They confirmed that they are going to apply for Orphan Drug Status. I know many of us anticipated this, but it's great to hear confirmation.
2. They have a Principle Investigator in place for the clinical trials. So once the approval happens, it sounds like we're off to the races on that.
3. They confirmed that if the Aplastic Anemia trials are successful they plan to expand HemaXellerate to larger blood production disorders.
4. They plan to acquire the cancer patent, file an IND for that, and initiate clinical trials for it by the end of the year.
Seems like it's going to be an exciting year for BMSN!
